Live Breaking News & Updates on Mayer Professor

Stay updated with breaking news from Mayer professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nephrology Month in Review: April 2024

This month in review highlights top coverage of the latest news in nephrology, ranging from new clinical trial data in IgAN to research about kidney disease management. ....

United States , Manisha Jhamb , Jonathan Barratt , Alpine Immune Sciences , American Society Of Nephrology , International Society Of Nephrology , European Renal Association , University Of Pittsburgh School Medicine , University Of Leicester , World Congress , World Health Organization , Nephrology Month , Mayer Professor , Renal Medicine , Calliditas Therapeutics , Improve Nephrology , Pittsburgh School , American Society , International Society , Deidra Crews ,

Jonathan Barratt, MD: Atacicept Could 'Transform How We Think About Treating IgA Nephropathy'

Barratt explained findings from the phase 2b ORIGIN trial of atacicept and how it compares to current standard therapies in IgAN and other agents in the pipeline. ....

Jonathan Barratt , University Of Leicester , Mayer Professor , Renal Medicine ,

Updated Clinical Data for Povetacicept in IgA Nephropathy Support Advancement to Phase 3 Trial

RUBY-3 findings support povetacicept’s ability to induce remission, reduce UPCR, stabilize renal function, and resolve hematuria in patients with IgAN. ....

Buenos Aires , Distrito Federal , Jonathan Barratt , Pbudesonide Tarpeyo , Iga Nephropathy Foundation Jonathan Barratt , Alpine Immune Sciences Shares Updated Clinical Data , Alpine Immune Sciences , World Congress , University Of Leicester , Drug Administration , Iga Nephropathy Foundation , Immune Sciences , Mayer Professor , Renal Medicine , Full Approval , Shows Promise ,

Socioeconomically Deprived Patients with IgAN Face Worse Kidney Outcomes

Results highlighted an association between socioeconomic deprivation and greater risk of progression to kidney failure in patients with IgAN. ....

United Kingdom , Jonathan Barratt , Iga Nephropathy Foundation Jonathan Barratt , University Of Leicester , Iga Nephropathy Foundation , Multiple Deprivation , Mayer Professor , Renal Medicine , United Kingdom National Registry , Rare Kidney Diseases , Immunoglobina Nephropathy , Kidney Disease , Kidney Failure , Socioeconomic Deprivation ,

Preliminary Data from SPARTAN Trial Presented at ASN 2023

Preliminary data from the SPARTAN study were presented at ASN Kidney Week 2023, demonstrating sparsentan’s impact on proteinuria and total body water over time. ....

United States , Jonathan Barratt , Iga Nephropathy Foundation Jonathan Barratt , Drug Administration , American Society Of Nephrology Kidney Week , University Of Leicester , Iga Nephropathy Foundation , American Society , Nephrology Kidney Week , Mayer Professor , Renal Medicine , Immunoglobulina Nephropathy ,